Keros Therapeutics Inc. logo

Keros Therapeutics Inc. (KROS)

Market Closed
15 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
21. 22
-0.29
-1.35%
$
709.43M Market Cap
- P/E Ratio
0% Div Yield
436,059 Volume
-5.27 Eps
$ 21.51
Previous Close
Day Range
20.73 21.29
Year Range
9.12 22.55
Want to track KROS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 71 days
Name Time Cons. EPS Eps
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
25 Feb 2026 (In 2 months)
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
5 Nov 2025
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
30 Oct 2025
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
31 Jul 2025
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
6 May 2025
0.01
3.62
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
26 Feb 2025
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
4 Nov 2024
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
5 Aug 2024
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
30 May 2024
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
2 May 2024
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
1 Mar 2024
-
-
Keros Therapeutics Inc. logo
KROS Keros Therapeutics Inc.
1 Nov 2023
-
-

KROS Earnings Reports FAQ

What is the earnings per share (EPS) for KROS?

The current EPS is -5.27.

What is the company's earnings growth rate?

Keros Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-25, based on the KROS's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Keros Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for KROS at this time, as Keros Therapeutics Inc has no recent EPS data to calculate it.